Moberg Pharma AB (publ) (MOB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.002x

Based on the latest financial reports, Moberg Pharma AB (publ) (MOB) has a cash flow conversion efficiency ratio of 0.002x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.52 Million ≈ $163.36K USD) by net assets (Skr665.22 Million ≈ $71.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Moberg Pharma AB (publ) stock valuation for the company's overall valuation and market capitalisation.

Moberg Pharma AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Moberg Pharma AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Moberg Pharma AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Moberg Pharma AB (publ) ranked by their cash flow conversion efficiency. Explore MOB cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Intrum Justitia AB ST:INTRUM	0.059x
Dogwood Therapeutics, Inc. NASDAQ:DWTX	-0.042x
Microtips Technology TWO:3285	-0.027x
PTL Enterprises Limited NSE:PTL	0.025x
Centrepoint Alliance Ltd AU:CAF	0.085x
Envoy Medical Inc. NASDAQ:COCH	-1.652x
Decibel Cannabis Company Inc V:DB	0.028x
Daewon Media Co. Ltd KQ:048910	0.095x

Annual Cash Flow Conversion Efficiency for Moberg Pharma AB (publ) (2008–2025)

The table below shows the annual cash flow conversion efficiency of Moberg Pharma AB (publ) from 2008 to 2025. View today's stock price for Moberg Pharma AB (publ) for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr665.22 Million ≈ $71.59 Million	Skr-17.49 Million ≈ $-1.88 Million	-0.026x	-9.63%
2024-12-31	Skr686.82 Million ≈ $73.91 Million	Skr-16.47 Million ≈ $-1.77 Million	-0.024x	+55.89%
2023-12-31	Skr610.73 Million ≈ $65.72 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.054x	-72.25%
2022-12-31	Skr533.58 Million ≈ $57.42 Million	Skr-16.84 Million ≈ $-1.81 Million	-0.032x	+10.43%
2021-12-31	Skr434.05 Million ≈ $46.71 Million	Skr-15.30 Million ≈ $-1.65 Million	-0.035x	+53.42%
2020-12-31	Skr395.58 Million ≈ $42.57 Million	Skr-29.93 Million ≈ $-3.22 Million	-0.076x	-302.29%
2019-12-31	Skr105.68 Million ≈ $11.37 Million	Skr3.95 Million ≈ $425.30K	0.037x	-69.94%
2018-12-31	Skr594.02 Million ≈ $63.93 Million	Skr73.89 Million ≈ $7.95 Million	0.124x	+27.68%
2017-12-31	Skr552.41 Million ≈ $59.45 Million	Skr53.82 Million ≈ $5.79 Million	0.097x	+404.98%
2016-12-31	Skr561.62 Million ≈ $60.44 Million	Skr-17.94 Million ≈ $-1.93 Million	-0.032x	-136.69%
2015-12-31	Skr352.82 Million ≈ $37.97 Million	Skr30.72 Million ≈ $3.31 Million	0.087x	+63.63%
2014-12-31	Skr303.75 Million ≈ $32.69 Million	Skr16.16 Million ≈ $1.74 Million	0.053x	+440.35%
2013-12-31	Skr201.49 Million ≈ $21.68 Million	Skr-3.15 Million ≈ $-338.99K	-0.016x	-129.40%
2012-12-31	Skr178.23 Million ≈ $19.18 Million	Skr9.48 Million ≈ $1.02 Million	0.053x	+145.26%
2011-12-31	Skr76.79 Million ≈ $8.26 Million	Skr-9.02 Million ≈ $-970.70K	-0.117x	+99.73%
2010-12-31	Skr687.70K ≈ $74.01K	Skr-30.41 Million ≈ $-3.27 Million	-44.224x	-5189.34%
2009-12-31	Skr30.21 Million ≈ $3.25 Million	Skr-25.26 Million ≈ $-2.72 Million	-0.836x	+63.51%
2008-12-31	Skr15.23 Million ≈ $1.64 Million	Skr-34.89 Million ≈ $-3.75 Million	-2.291x	--

About Moberg Pharma AB (publ)

ST:MOB Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$54.83 Million

Skr509.49 Million SEK

Market Cap Rank

#21658 Global

#392 in Sweden

Share Price

Skr10.84

Change (1 day)

+2.26%

52-Week Range

Skr7.79 - Skr12.40

All Time High

Skr226.13